Buscar
Mostrando ítems 1-10 de 32
Targeted radionuclide therapy: frontiers in theranostics
(Landmark, 2017-06-01)
The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear medicine as treating agents, targeted at the cellular or molecular level. The growth of the interest in TRT was stimulated by the ...
Comparison between three promising β-emitting radionuclides, 67Cu, 47Sc and 161Tb, with emphasis on doses delivered to minimal residual disease
(Ivyspring International Publisher, 2016-06)
PURPOSE: Radionuclide therapy is increasingly seen as a promising option to target minimal residual disease. Copper-67, scandium-47 and terbium-161 have a medium-energy β- emission which is similar to that of lutetium-177, ...
Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer
(2017-03-06)
Purpose: Compare the lymphatic flow in the arm after breast cancer surgery and axillary lymph node dissection (ALND) versus sentinel lymph node biopsy (SLNB) using lymphoscintigraphy (LS). Patients and methods: A cross-sectional ...
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTATO,Tyr3]-octreotate
(2018-11-29)
Background: This study’s aim was to develop our dosimetric methodology using a commercial workstation for the
routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu.
Methods: ...
Prediction of palladium-103 production using the Monte Carlo code MCNPX
(PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, 2013)
Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy
(2020)
Purpose
Small-scale dosimetry studies generally consider an artificial environment where the tumors are spherical and the radionuclides are homogeneously biodistributed. However, tumor shapes are irregular and radiopharmaceutical ...
[177Lu – DOTA – Tyr3] – OCTREOTATE para el tratamiento de tumores neuroendocrinos gastroenteropancreáticos. Revisión sistemática de la literatura.
(Universidad del RosarioEspecialización en Medicina NuclearFacultad de Medicina, 2013)
Gastroenteropancreatic neuroendocrine tumors are diagnosed in advanced state in approximately 60 – 80% of patients, their treatment options are limited. We reviewed the clinical benefit of radionuclide therapy with 177Lu ...
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group
(Cancer Intelligence Ltd, 2017)
Neuroendocrine tumours are a heterogeneous group of diseases with a significant variety of diagnostic tests and treatment modalities. Guidelines were developed by North American and European groups to recommend their best ...